Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Cognition Therapeutics, Inc. (CGTX)

NASDAQ

$1,02

$+0,01

(+1,19%)

Pre-Market

Cognition Therapeutics, Inc. (CGTX) Live Price Chart

Last updated: ⁦2026-09-16 12:18:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Cognition Therapeutics, Inc. (CGTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1,02, with a market capitalisation of $96,04M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,55 to $2,05. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$96,04M
Open	$1,00
Day's High	$13,80
Day's Low	$0,22
Previous Close	$1,03
Volume	2,50K
Average Volume	1,15M
P/E Ratio	--
52-Week High	$2,05
52-Week Low	$0,55
Dividend Yield	--
Earnings Date	--

Cognition Therapeutics, Inc. (CGTX) Pre-Market Stock Price

Cognition Therapeutics, Inc. (CGTX) is trading at $1,02 in pre-market trading as of 2026-09-16 12:00:00, down 1,74% ($0,02) from the previous close of $1,04

Pre-market trading shows how investors are pricing CGTX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Cognition Therapeutics, Inc. (CGTX) 7-Day Stock Price Change

Over the past seven days, Cognition Therapeutics, Inc. (CGTX) moved from $1,03 to $1,02, representing a decline of 1,26% ($0,01).

The stock traded between $0,97 and $1,05 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 355,71 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

CGTX 52-Week Price Position

Position in Range: 31,1%

52W Low$0,55

52W High$2,05

CGTX is currently trading at $1,02, placing it 31,1% of the way from its 52-week low of $0,55 to its 52-week high of $2,05. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cognition Therapeutics, Inc. (CGTX)?

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Cognition Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	14
Exchange	NASDAQ
Company Website	https://www.cogrx.com

How to Buy Cognition Therapeutics, Inc. (CGTX) Stock on MEXC

Eligible investors can buy real shares of Cognition Therapeutics, Inc. (CGTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CGTX and Place Your Order

Open the RealStocks trading page and search for CGTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cognition Therapeutics, Inc. (CGTX) stock price today?

Cognition Therapeutics, Inc. (CGTX) is currently trading at $ 1,02, down 1,74% ($0,02) from the previous close of $ 1,04. Intraday prices update in real time during regular trading hours.

2.Is CGTX stock going up or down today?

As of 2026-09-16 12:00:00, CGTX is trading at $ 1,02, down 1,74% ($0,02) from its previous close of $ 1,04. The stock has traded between $ 0,22 and $ 13,80 during today’s regular session. Past price movements do not guarantee future results.

3.What is CGTX pre-market price?

As of 2026-09-16 12:00:00, CGTX is trading at $ 1,02 in pre-market trading, down 1,74% ($0,02) from the previous close of $ 1,04. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CGTX after-hours price?

As of 2026-09-16 12:00:00, CGTX is trading at $ 1,01 in after-hours trading, down 2,90% ($0,03) from the regular-session close of $ 1,04. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CGTX stock trading now?

CGTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CGTX sit relative to its 52-week high and low?

Over the past 52 weeks, CGTX has traded between a low of $ 0,55 and a high of $ 2,05. At $ 1,02, the stock is positioned 31,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cognition Therapeutics, Inc. in?

Cognition Therapeutics, Inc. (CGTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cognition Therapeutics, Inc.'s market capitalisation and where is it listed?

Cognition Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 96,04M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CGTX valued in terms of P/E ratio and EPS?

CGTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cognition Therapeutics, Inc. pay a dividend?

Cognition Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.